The Chase Group Executive Search Logo
“Committed to Excellence in Life Sciences Executive Search”

Esperion Therapeutics Retains The Chase Group to Fill Chief Commercial Officer Role

April 7, 2017
Esperion Therapeutics has retained The Chase Group to secure a Chief Commercial Officer to provide the leadership, strategic vision, and functional expertise to drive the company to successful commercialization of the company’s LDL-C lowering therapies. This executive leader will have demonstrated success in building a commercial organization and launching products that significantly impact patients’ lives. For confidential consideration, contact Bonnie at

Chase Group

Share This News Post

© Copyright 1993-2022 The Chase Group; All Rights Reserved.